Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-18T22:42:39.382Z Has data issue: false hasContentIssue false

Hormonal programming in perinatal life: leptin and beyond

Published online by Cambridge University Press:  05 August 2008

Andreas Plagemann*
Affiliation:
Clinic of Obstetrics, Research Group ‘Experimental Obstetrics’, Charité – University Medicine Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353Berlin, Germany
Thomas Harder
Affiliation:
Clinic of Obstetrics, Research Group ‘Experimental Obstetrics’, Charité – University Medicine Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353Berlin, Germany
*
*Corresponding author: Professor Dr med. Andreas Plagemann, fax +49 30 450 52 49 28, email [email protected]
Rights & Permissions [Opens in a new window]

Extract

Central nervous system leptin resistance as a possible cause of obesity and associated diseases is a ‘hot topic’ in nutrition research. Simultaneously, a new field in biomedical sciences has evolved during the past years.

Type
Invited Commentary
Copyright
Copyright © The Authors 2008

Central nervous system leptin resistance as a possible cause of obesity and associated diseases is a ‘hot topic’ in nutrition research. Simultaneously, a new field in biomedical sciences has evolved during the past years. ‘Perinatal programming’ addresses the phenomenon of early (hormonal, nutritional, metabolic etc.) priming of fundamental life functions during critical periods of pre- and neonatal development, potentially causing lasting malfunctions in the case of altered early conditions. The current wide recognition of this field was mainly ‘triggered’ during recent years by the ‘Barker hypothesis’ on a ‘small-baby syndrome’(Reference Hales and Barker1). However, by looking into the literature one has to realize that this concept has scientific roots that go back at least to the 1970s. In fact, more than 30 years ago the German endocrinologist Günter Dörner introduced the term ‘perinatal programming’ and the concept of hormone-dependent ‘functional teratogenesis’ of neuro-endocrine networks(Reference Dörner, Stumpf and Grant2, Reference Dörner3). According to Dörner, hormones play a crucial role in the developmental determination of the functional ranges (which actually is a better term for what often is named ‘set point’) of neuro-endocrine systems regulating key functions of the organism like, e.g., food intake, stress response and reproduction. If hormones occur in non-physiological concentrations during critical periods of development, the functional range of the respective system becomes permanently changed. This malprogramming of regulatory systems may have long-term consequences: permanently changed responses to key signals like those mediating satiety can increase the susceptibility to develop diseases in later life like, for example, obesity, diabetes and accompanying CVD. Other investigators have developed similar concepts named, for example, ‘fuel-mediated teratogenesis’(Reference Freinkel4) or ‘nutritional programming’(Reference Lucas, Bock and Whelan5). However, credit is due to Dörner for having introduced a general cybernetic concept which highlights the key position of hormones with regard to the self-organization of regulatory systems of the organism, like those regulating food intake, body weight and metabolism.

In this issue of the British Journal of Nutrition, Passos et al. provide an interesting contribution to the ongoing research on hormonal programming(Reference Passos, Toste, Dutra, Trotta, Toste, Lisboa and de Moura6). They show that exogenous induction of hyperleptinaemia during the first 10 d of life in rats leads to leptin resistance at adult age. Leptin resistance was functionally verified by the absence of a decrease in food intake in response to leptin injection as well as by a decreased expression of the hypothalamic leptin receptor and an increased expression of SOCS-3, a mediator of leptin resistance, in neonatally leptin-treated rats. This is the second publication from that group indicating that increased levels of leptin during neonatal life may programme leptin resistance, with adverse consequences for the regulation of body weight and metabolism(Reference Passos, Toste, Dutra, Trotta, Toste, Lisboa and de Moura6, Reference Toste, Moura, Lisboa, Fagundes, Oliveira and Passos7). More generally, Passos et al. extend previous work by our group showing paradigmatically that hormonal programming does not exclusively apply to steroid hormones, but can be extended to proteohormones. In fact, while the impact of altered levels of sex steroids or glucocorticoids, which are, for example, induced by stress exposure during early development, can be considered to be an established mechanism of hormonal programming(Reference Dörner, Stumpf and Grant2, Reference Dörner3, Reference McEwen8, Reference Szyf, Weaver, Champagne, Diorio and Meaney9), a comparable role of peptides, proteohormones and cytokines was rarely investigated, nor even considered for a long time. First results pointing in that direction came from experiments which investigated the long-term consequences of increased levels of insulin during perinatal life for later adipogenic and metabolic risk. These early data indicated that perinatal hyperinsulinism, as it typically occurs in the offspring of mothers with diabetes during pregnancy, leads to malprogramming of hypothalamic circuits regulating food intake, body weight and metabolism(Reference Dörner, Plagemann, Rückert, Götz, Rohde, Stahl, Kürschner, Gottschalk, Mohnike and Steindel10Reference Plagemann12). Consequences of exposure to perinatal hyperinsulinism as well as hyperleptinism were investigated, for example in rats which were raised in ‘small litters’, a well-established model of neonatal overnutrition. Hyperleptinaemia within the first days of life was followed by persisting overweight, hyperphagia, diabetogenic and cardiovascular disturbances throughout later life(Reference Plagemann, Harder, Rake, Voits, Fink, Rohde and Dörner13). This was associated with hypothalamic neuronal alterations indicating neonatally acquired leptin resistance, persisting into adult age and leading to a persisting adipogenic and diabetogenic phenotype(Reference Plagemann, Harder, Rake, Voits, Fink, Rohde and Dörner13Reference Davidowa and Plagemann16). Further data obtained in this model impressively confirmed these findings(Reference Boullu-Ciocca, Dutour, Guillaume, Achard, Oliver and Grino17, Reference López, Seoane, Tovar, García, Nogueiras, Diéguez and Señaris18), in line with the observations by Passos and co-workers(Reference Passos, Toste, Dutra, Trotta, Toste, Lisboa and de Moura6, Reference Toste, Moura, Lisboa, Fagundes, Oliveira and Passos7).

However, at first view all of this seems to contrast observations published by Vickers et al. (Reference Vickers, Gluckman, Coveny, Hofman, Cutfield, Gertler, Breier and Harris19). Here, neonatal leptin treatment was shown to protect neonatally growth-restricted offspring of rat dams undernourished during gestation from developing overweight during later life. Similarly, in mice carrying a strong genetic predisposition to obesity due to the absence of leptin (ob/ob), Bouret et al. observed that neonatal leptin injections reduced the development of the typical obese phenotype(Reference Bouret, Draper and Simerly20). Interestingly enough, however, only recently Vickers et al. observed essentially the opposite of their previous findings when investigating offspring of normally nourished dams(Reference Vickers, Gluckman, Coveny, Hofman, Cutfield, Gertler, Breier and Harris21), in accordance with former observations(Reference Plagemann, Harder, Rake, Voits, Fink, Rohde and Dörner13Reference López, Seoane, Tovar, García, Nogueiras, Diéguez and Señaris18).

Moreover, against the background of epidemiological and clinical observations, all of this indicates that both unphysiologically high as well as low levels of leptin during perinatal life may have essentially similar consequences for long-term adipogenic and metabolic risk. This is phenomenologically supported by epidemiological data indicating a u-shaped relation between birth weight and subsequent metabolic risk(Reference Harder, Rodekamp, Schellong, Dudenhausen and Plagemann22), rather than the widely suggested and recognized inverse relation. It can therefore be postulated that leptin substitution in leptin-deficient states during early development may be beneficial for later outcome while hyperleptinaemia during critical periods seems to have long-term adverse consequences.

Studies like those by Passos and co-workers(Reference Passos, Toste, Dutra, Trotta, Toste, Lisboa and de Moura6, Reference Toste, Moura, Lisboa, Fagundes, Oliveira and Passos7) are important because they may bridge between apparently contradictory observations and phenomena, helping to integrate empirical, epidemiological and experimental data, and, most of all, uncover concrete pathophysiological factors leading to early malprogramming of the regulation of body weight and metabolism. Understanding the causes of obesity epidemics will critically depend on studies evaluating its developmental origins and, thereby, revealing a basis for primary prevention.

References

1Hales, CN & Barker, DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35, 595601.CrossRefGoogle ScholarPubMed
2Dörner, G (1975) Perinatal hormone levels and brain organization. In Anatomical Neuroendocrinology, pp. 245252 [Stumpf, WE and Grant, LD, editors]. Basel: Karger.Google Scholar
3Dörner, G (1976) Hormones and Brain Differentiation. Amsterdam: Elsevier.Google Scholar
4Freinkel, N (1980) Of pregnancy and progeny: banting lecture 1980. Diabetes 29, 10231035.CrossRefGoogle ScholarPubMed
5Lucas, A (1991) Programming by early nutrition in man. In The Childhood Environment and Adult Disease. Ciba Foundation Symposium 156, pp. 3855 [Bock, GR and Whelan, J, editors]. Chichester: Wiley.Google Scholar
6Passos, MCF, Toste, FP, Dutra, SCP, Trotta, PA, Toste, FP, Lisboa, PC & de Moura, EG (2008) Role of neonatal hyperleptinemia on serum adiponectin and SOCS-3 expression in young rats. Br J Nutr (Epublication ahead of print version).CrossRefGoogle Scholar
7Toste, FP, Moura, EG, Lisboa, PC, Fagundes, AT, Oliveira, E & Passos, MCF (2006) Neonatal leptin treatment programmes hypothalamic leptin resistance and intermediary metabolic parameters in adult rats. Br J Nutr 95, 830837.CrossRefGoogle ScholarPubMed
8McEwen, BS (1992) Steroid hormones: effects on brain development and function. Horm Res 37, 110.CrossRefGoogle Scholar
9Szyf, M, Weaver, IC, Champagne, FA, Diorio, J & Meaney, MJ (2005) Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front Neuroendocrinol 26, 139162.CrossRefGoogle ScholarPubMed
10Dörner, G, Plagemann, A, Rückert, J, Götz, F, Rohde, W, Stahl, F, Kürschner, U, Gottschalk, J, Mohnike, A & Steindel, E (1988) Teratogenetic maternofetal transmission and prevention of diabetes susceptibility. Exp Clin Endocrinol 91, 247258.CrossRefGoogle ScholarPubMed
11Dörner, G & Plagemann, A (1994) Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm Metab Res 26, 213221.CrossRefGoogle ScholarPubMed
12Plagemann, A (2004) ‘Fetal programming’ and ‘functional teratogenesis’: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks. J Perinat Med 32, 297305.CrossRefGoogle ScholarPubMed
13Plagemann, A, Harder, T, Rake, A, Voits, M, Fink, H, Rohde, W & Dörner, G (1999) Perinatal increase of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome X-like alterations in adulthood of neonatally overfed rats. Brain Res 836, 146155.CrossRefGoogle ScholarPubMed
14Plagemann, A, Harder, T, Rake, A, Waas, T, Melchior, K, Ziska, T, Rohde, W & Dörner, G (1999) Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats. J Neuroendocrinol 11, 541546.CrossRefGoogle ScholarPubMed
15Schmidt, I, Fritz, A, Schoelch, C, Schneider, D, Simon, E & Plagemann, A (2001) The effect of leptin treatment on the development of obesity in overfed suckling Wistar rats. Int J Obes 25, 11681174.CrossRefGoogle ScholarPubMed
16Davidowa, H & Plagemann, A (2000) Decreased inhibition by leptin of hypothalamic arcuate neurons in neonatally overfed young rats. NeuroReport 11, 27952798.CrossRefGoogle ScholarPubMed
17Boullu-Ciocca, S, Dutour, A, Guillaume, V, Achard, V, Oliver, C & Grino, M (2005) Postnatal diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood. Diabetes 54, 197203.CrossRefGoogle ScholarPubMed
18López, M, Seoane, LM, Tovar, S, García, MC, Nogueiras, R, Diéguez, C & Señaris, RM (2005) A possible role of neuropeptide Y, agouti-related protein and leptin receptor isoforms in hypothalamic programming by perinatal feeding in the rat. Diabetologia 48, 140148.CrossRefGoogle ScholarPubMed
19Vickers, MH, Gluckman, PD, Coveny, AH, Hofman, PL, Cutfield, WS, Gertler, A, Breier, BH & Harris, M (2005) Neonatal leptin treatment reverses developmental programming. Endocrinology 146, 42114216.CrossRefGoogle ScholarPubMed
20Bouret, SG, Draper, SJ & Simerly, RB (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304, 108110.CrossRefGoogle ScholarPubMed
21Vickers, MH, Gluckman, PD, Coveny, AH, Hofman, PL, Cutfield, WS, Gertler, A, Breier, BH & Harris, M (2008) The effect of neonatal leptin treatment on postnatal weight gain in male rats is dependent on maternal nutritional status during pregnancy. Endocrinology 149, 19061913.CrossRefGoogle ScholarPubMed
22Harder, T, Rodekamp, E, Schellong, K, Dudenhausen, JW & Plagemann, A (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 165, 849857.CrossRefGoogle ScholarPubMed